Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
Zurzuvae, the recently FDA-approved pill to treat postpartum depression. (Image: Getty; illustration by Alex Cochran for Yahoo) In August the Food and Drug Administration approved Zurzuvae (zuranolone ...
Investor's Business Daily on MSN
Psychedelics-tied GH skyrockets on FDA go-ahead for depression drug
Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug.
Stacker on MSN
New anxiety medications are in the pipeline for 2026
LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...
A new study out of Stanford Medicine has found a “new category of depression” that impacts 27% of diagnosed individuals and is “not effectively” treated by standard antidepressants. Specifically, this ...
Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...
Let's go into some of the barriers to access for women who are suffering from postpartum depression. The barriers are multi. So I don't think that I can kind of even communicate all of them to you ...
Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results